Clincosm LogoSign in Get a demo

renal neoplasms

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

Completed
Has Results
  • Cancer of Kidney
  • +6 more
  • 124-Iodine-cG250 (124I-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

NSCLC (NSCLC), Non-Small-Cell Lung Carcinoma, Nonsmall Cell Lung Cancer Trial in India (Nivolumab)

Completed
Has Results
  • Non-Small Cell Lung Cancer (NSCLC)
  • +6 more
  • Bangalore, India
  • +8 more
Dec 3, 2020

Extracolonic Findings on Computed Tomography (CT) Colonography

Unknown status
  • Solitary Pulmonary Nodules
  • +8 more
    • (no location specified)
    Oct 9, 2018

    Renal Tumors, Targeted Molecular Therapy Trial (sunitinib)

    Not yet recruiting
    • Renal Neoplasms
    • Targeted Molecular Therapy
    • (no location specified)
    Feb 24, 2016

    Lung Tumors, Ovarian Tumors, Cervix Tumors Trial run by the NCI (docetaxel, tariquidar, 99mTc-sestamibi imaging)

    Completed
    Has Results
    • Lung Neoplasms
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health
    Sep 12, 2012